GW Pharmaceuticals reports Epidiolex sales of $296 million in first year

The British biopharmaceutical company has released Q4 and 2019 financial year results

picture of

Breaking News

Boehringer Ingelheim to open hub in China

Boehringer has invested an initial €3 million to open a second branch of its digital lab BI X in Shanghai

UK companies combine instruments with analytical services

UK-based Malvern Panalytical and Concept Life Sciences have launched a new partnership that combines capabilities for ...

Next-generation diagnostics identified as a key investment area for healthcare digitalisation

Digitalisation is already helping to address a number of disparities in the healthcare landscape; but, in such a ...

BioCity predicts proliferation of workspace amid life science ventures boom

The UK's life science incubator has released the Life Science Start-Up Report with in-depth analysis of emerging ...

Evox Therapeutics and Takeda sign multitarget rare disease collaboration

Collaboration focuses on developing novel protein replacement and mRNA therapies and explores the targeted delivery of ...

Report investigates where the weak link in the supply chain is

COVID-19 has meant staff are working from home, however, it’s a different situation for manufacturers

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market

ACG provides update on the status of its factories

The global company has instituted working from home and is developing a crisis plan in case an emergency situation ...

Albumedix establishes new regulatory department following DMF acceptance

One of six main centres for the US FDA has accepted a Drug Master File (DMF) submission for the Albumedix’s ...

What happens if a company doesn’t have any records of its R&D activities?

Companies in the UK engaged in R&D can get up to 33% of innovation expenditures back. Myriad Associates explains how to ...

Addressing the need for cost-effective vaccine manufacturing

Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost- ...

An automatic response to businesses’ financial woes

The UK business world is in crisis. It might sound like an over-dramatic statement; however, from a financial ...

Fosun Pharma invests $50m in BioNTech for its COVID-19 vaccine

The two companies have agreed to develop BNT162 in China leveraging Fosun’s capabilities in the country

Tepnel Pharma Services takes first step towards employee ownership

The QC company's transition to employee-ownership has been set in motion to generate a reciprocal culture that is on ...